Transfusion medicine

Recent Updates

Modified on:

Feb 12, 2021

COVID-19 and transfusion medicine

http://cancovid19plasma.ca/This repository aims to support Canadian transfusion medicine health care professionals during the COVID-19 pandemic. It will be updated regularly as new information is available. In addition, the public and donors can learn more about how Canadian Blood Services is responding to COVID-19 by visiting blood.ca/covid-19.

Twitter Facebook LinkedIn Forward

Published:

Jan 15, 2021

Blood Components

Chapter 2

Whole blood donations are separated into specific cellular (red blood cells and platelets) and plasma components. Transfusing the appropriate blood component to effectively provide for the clinical needs of patients optimizes use of donated blood.

This chapter describes the manufacturing process for the most commonly prepared blood components:

Red blood cells (RBC)
Platelets: pooled and apheresis
Frozen plasma (FP)
Apheresis fresh frozen plasma (AFFP)
Cryosupernatant plasma (CSP)
Cryoprecipitate

Twitter Facebook LinkedIn Forward

Published:

Oct 6, 2020

Blood Administration

Chapter 9

This chapter focuses on the principles of safe blood transfusion practices. The aim of this chapter is to develop and support the knowledge of health-care professionals involved in prescribing and administering blood components and products.

Upcoming Events

U of T Rounds: Fetal-Neonatal Alloimmune Thrombocytopenia (FNAIT): Diagnosis, investigation and treatment

Twitter Facebook LinkedIn Forward

When

February 25, 2021 | 12:00PM to 1:00PM

Where

Toronto/Webinar

Presented by:

Dr. Lani Lieberman MD, FRCPC
Assistant Professor, University of Toronto
Transfusion Medicine Specialist, University Health Network and affiliated hospitals

Ms. Lynnette Beaudin
Manager - Process Development – DS Testing
Canadian Blood Services

Learning Objectives:

1. To identify the clinical and laboratory features that characterize fetal/neonatal alloimmune thrombocytopenia.
2. To develop an understanding to the approach of maternal and neonatal treatment.

Journal Club

Twitter Facebook LinkedIn Forward

When

March 2, 2021 | 12:00PM to 1:00PM

Where

Toronto/Webinar

More details to follow.

Note: The session is a self-approved group learning activity (Section 1) as defined by the Maintenance of Certification program of The Royal College of Physicians and Surgeons of Canada.

Journal Club

Twitter Facebook LinkedIn Forward

When

March 9, 2021 | 12:00PM to 1:00PM

Where

Toronto/Webinar

More details to follow.

Note: The session is a self-approved group learning activity (Section 1) as defined by the Maintenance of Certification program of The Royal College of Physicians and Surgeons of Canada.

Blog

Modified on:

Feb 17, 2021

Twitter Facebook LinkedIn Forward

The START Study: Improving red blood cell use in Canadian hospitals

A study conducted by researchers in the University of Toronto QUEST program, a research collaborative supported by Canadian Blood Services, looked at what can be done to reduce the number of inappropriate red blood cell transfusions in hospitals.

Modified on:

Feb 8, 2021

Twitter Facebook LinkedIn Forward

IVIg alternative for surgery patients with bleeding disorder

With an anticipated global shortage of immune globulin products, finding alternatives to IVIg can help improve availability of a drug in high demand. A recent study shows that eltrombopag, an oral medication that stimulates the production of platelets, is an effective alternative to IVIg for patients with immune thrombocytopenia who need surgery.

Modified on:

Jan 28, 2021

Twitter Facebook LinkedIn Forward

Call for applications! Research funding opportunities now open

The Intramural Research Grant Program, one of the Centre for Innovation’s most responsive and impactful research funding programs, and the Kenneth J. Fyke Program, which supports health services and policy research, are both open for applications.